Circulating microRNAs are associated with variability in fasting blood glucose over 12-months and target pathways related to type 2 diabetes: A pilot study

1. Flowers, E, Aouizerat, BE, Abbasi, F, et al. Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: moving towards precision health for diabetes prevention. Metabolism 2015. DOI: 10.1016/j.metabol.2015.05.013
Google Scholar | Crossref | Medline2. Flowers, E, Gadgil, M, Aouizerat, BE, et al. Circulating micrornas associated with glycemic impairment and progression in Asian Indians. Biomarker Res 2015; 3(1): 1–8.
Google Scholar | Crossref3. Chou, CH, Shrestha, S, Yang, CD, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res 2018; 46(D1): D296–D302.
Google Scholar | Crossref | Medline4. Backes, C, Kehl, T, Stockel, D, et al. miRPathDB: a new dictionary on microRNAs and target pathways. Nucleic Acids Res 2017; 45(D1): D90–D6.
Google Scholar | Crossref | Medline5. Fox, CS, Liu, Y, White, CC, et al. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS Genet 2012; 8(5): e1002695.
Google Scholar | Crossref | Medline6. Min, KH, Yang, WM, Lee, W. Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes. Biochem Biophys Res Commun 2018; 503(3): 1587–1593.
Google Scholar | Crossref | Medline7. Lang, H, Xiang, Y, Lin, N, et al. Identification of a panel of MiRNAs as positive regulators of insulin release in pancreatic beta-cells. Cell Physiol Biochem 2018; 48(1): 185–193.
Google Scholar | Crossref | Medline8. Wang, G, Gu, Y, Xu, N, et al. Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: Association with ongoing islet autoimmunity. Biochem Biophys Res Commun 2018; 498(3): 382–387.
Google Scholar | Crossref | Medline9. Snowhite, IV, Allende, G, Sosenko, J, et al. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes. Diabetologia 2017; 60(8): 1409–1422.
Google Scholar | Crossref | Medline10. Joglekar, MV, Wong, WKM, Maynard, CL, et al. Expression of miR-206 in human islets and its role in glucokinase regulation. Am J Physiol Endocrinol Metab 2018; 315(4): E634–E637.
Google Scholar | Crossref | Medline11. Chen, YH, Heneidi, S, Lee, JM, et al. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes 2013; 62(7): 2278–2286.
Google Scholar | Crossref | Medline12. Huang, X, Liu, G, Guo, J, et al. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci 2018; 14(11): 1483–1496.
Google Scholar | Crossref | Medline13. Angeles, TS, Hudkins, RL. Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors. Expert Opin Drug Discov 2016; 11(12): 1187–1199.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif